BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30936598)

  • 1. NDRG2 Regulates the Expression of Genes Involved in Epithelial Mesenchymal Transition of Prostate Cancer Cells.
    Moradi Monfared M; Alizadeh Zarei M; Rafiei Dehbidi G; Behzad Behbahani A; Arabsolghar R; Takhshid MA
    Iran J Med Sci; 2019 Mar; 44(2):118-126. PubMed ID: 30936598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Overexpression of NDRG2 using Survivin Promoter Reduces Viability and Invasiveness of A549 Cell Line.
    Fanian M; Rafiei G; Alizadeh Zarei M; Takhshid MA
    Avicenna J Med Biotechnol; 2023; 15(2):84-90. PubMed ID: 37034887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of NDRG2 overexpression, X-ray radiation and docetaxel enhances apoptosis and inhibits invasiveness properties of LNCaP cells.
    Alizadeh Zarei M; Rafiei Dehbidi G; Takhshid MA
    Urol Oncol; 2020 Nov; 38(11):849.e1-849.e9. PubMed ID: 32665121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Effects of NDRG2 Overexpression and Radiotherapy on Cell Death of Human Prostate LNCaP Cells.
    Alizadeh Zarei M; Takhshid MA; Behzad Behbahani A; Hosseini SY; Okhovat MA; Rafiee Dehbidi GR; Mosleh Shirazi MA
    J Biomed Phys Eng; 2017 Sep; 7(3):257-264. PubMed ID: 29082216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
    Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
    Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitro.
    Faraji SN; Mojtahedi Z; Ghalamfarsa G; Takhshid MA
    Iran J Basic Med Sci; 2015 Aug; 18(8):773-9. PubMed ID: 26557966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
    Jin Z; Gu C; Tian F; Jia Z; Yang J
    Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer.
    Shen L; Qu X; Ma Y; Zheng J; Chu D; Liu B; Li X; Wang M; Xu C; Liu N; Yao L; Zhang J
    Oncogenesis; 2014 Feb; 3(2):e86. PubMed ID: 24492480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of NDRG2 Overexpression on Cell Proliferation and Invasiveness of SW48 Colorectal Cancer Cell Line.
    Golestan A; Mojtahedi Z; Ghalamfarsa G; Hamidinia M; Takhshid MA
    Iran J Med Sci; 2015 Sep; 40(5):430-9. PubMed ID: 26379350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HIF-1α and NDRG2 Expression with EMT in Gastric Cancer Tissues.
    Wang RX; Ou XW; Kang MF; Zhou ZP
    Open Life Sci; 2019 Jan; 14():217-223. PubMed ID: 33817155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
    Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
    Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma.
    Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
    BMC Complement Altern Med; 2014 Nov; 14():433. PubMed ID: 25370696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MTBP regulates migration and invasion of prostate cancer cells
    Xiao Z; Chen M; Yang J; Yang C; Lü X; Tian H; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):6-12. PubMed ID: 30692060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
    Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
    Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Annexin A5 overexpression on invasiveness and expression of the genes involved in epithelial-mesenchymal transition of HCT 116 cell line.
    Zamani B; Ramazani A; Saberzadeh J; Rostampour P; Takhshid MA
    Mol Biol Res Commun; 2023; 12(2):77-85. PubMed ID: 37520464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.